P53 and MDM2 protein expression in actinic cheilitis

Journal of Applied Oral Science

Volumn 16, Issue 6, 2008, Pages 414-419

  De Freitas, Maria Da Conceição Andrade ^a   Ramalho, Luciana Maria Pedreira ^a   Xavier, Flávia Caló Aquino ^a   Moreira, André Luis Gomes ^a   Reis, Silvia Regina Almeida ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Cheilitis; Immunohistochemistry; MDM2 protein; p53

Indexed keywords

EID: 58049158631     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/s1678-77572008000600011     Document Type: Article

References (32)

1. Agarwal S, Mathur M, Srivastava A. Ralhan R. MDM2/p53 coexpression in oral premalignanl and malignant lesions: potential prognostic implications. Oral Oncol. 1999;35:209-16.
2. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem. 1998;273(1):1-4.
3. Araújo VC, Martins MT, Leite KR, Gomes RS. Araújo NS. Immunohistochemical MDM2 expression in minor salivary gland tumours and its relationship to p53 gen status. Oral Oncol. 2000;36(1):67-9.
4. Banczy J. Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Surg. 1976;42(6):766-74.
5. Colman MS, Afshari CA, Barret JC. Regulation of p53 and activity in response to genotoxi stress. Mutat Res. 2000;462(2-3):179-88.
6. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM. p53 protein expression in malignant, pre-malignant and non- malignant lesions of the lip. J Clin Pathol. 1996;49(8):648-53.
7. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL. The role of the p53 tumor suppressor gene in squamous cell carcinoma of heas and neck. Arch Otolaryngol Head Neck Surg. 1993;119(10):1118-22.
8. Ganguli G, Abecassis J, Wasylyk B. MDM2 induces hyperplasia and premalignanl when expressed in the basal layer of the epidermis. EMBO J. 2000;19(19):5135-47.
9. Gomes APN, Araújo VC, Pinto Jr DS. Avaliação imuno-histoquímica de p53 e PCNA como marcadores de risco para lesões bucais potencialmente malignas. RPG Rev Pós Grad. 2000;7(4):349-55.
10. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistichemislry? Revisited! J Pathol. 1994;172(1):1-4.
11. Kaugars GE, Pillion T, Svirsky JA, Page DG, Burns JC, Abbey LM. Actinic cheilitis: a review of 152 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(2):181-6.
12. Kerdpon D, Rich AM, Reade PC, Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis. 1997;3(2):86-92.
13. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, et al. Alterations of p16INK4a and p14ARF in patients with severe oral epithelial dysplasia. Cancer Research. 2002;62(18):5295-300.
14. Kusama K, Okutsu S, Takeda A, Himiya A, Kidokoro Y, Chu L. et al. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol. 1996;178(4):415-21.
15. Lawall MA, Crivelini MM. PCNA and p53 expression in oral leukoplakia with different degrees of keratinization. J Appl Oral Sci. 2006;14(4):276-80.
16. Lee YS,Teh M. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin. Cancer. 1994;73(9):2317-23.
17. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M. et al. The 1993 Walter Hubert Lecture: the role of p53 tumour suppressor gene in lumorigenesis. Br J Cancer. 1994;69(3):409-16.
18. Lu S, Tiekso J, Hietanen S, Syrjänen K, Havu VK, Syrjänen S. Expression of cell-cycle protein p3. p21 (WAF-1 ), PCNA and Ki-67 in benign, premalignant skin lesions with implicated HPV involvement. Acta Derm Venereol. 1999;79:268-73.
19. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis. 2004;10(4):212-6.
20. Martínez A, Brethauer U, Rojas IG, Spencer M, Mucientes F. Borlando J, et al. Expression of apoplotic and cell proliferation regulatory proteins in actinic cheilitis. J Oral Pathol Med. 2005;34(5):257-62.
21. Martinez A. Brethauer U, Borlando J, Spencer ML. Rojas IG. Epithelial expression of p53, mdm-2 and p21 in normal lip and actinic cheilitis. Oral Oncol. 2008;44(9):878-83.
22. May P. May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene. 1999;18(53):7621-36.
23. Pimentel DR Neto, Michalany N, Alchorne M, Abreu M, Borra RC, Weckx L. Actinic cheilitis: histopathology and p53. J Cutan Pathol. 2006;33(8):539-44.
24. Pindborg JJ, Reichart PA, Smith CJ, van der Waal. Histological Typing of Cancer and Precancer of the Oral Mucosa. WHO International Classification of tumours. Berlin Heidelberg: Springer Verlag; 1997.
25. Regezi JA. Zarbo JR, Regev E, Plsanty S. Silverman S, Gazati D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med. 1995;24(1):18-22.
26. [de] Rosa I. Staibano S, Lo Muzio L, Delfino M, Lucariello A. Coppola A. de Rosa G, Scully C. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferation cell nuclear antigen. p53. and c-myc in differentiation and prognosis. J Oral Pathol Med. 1999;28(6):252-8.
27. Rowley H, Helliwell TR, Jones AS, Roland NJ, Field EA, Field JK. An immunohistochemical analysis of p53 protein expression in premalignant and malignant tissues of the oral cavity. Clin Otolaryngol Allied Sci. 1997;22(1):23-9.
28. Sano T, Hikino T, Xue Q, Saito T. Kashiwabara K, Oyama T. et al. Immunohistochemical inactivation of pi4ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma. Pathol Int. 2000;50(9):709-16.
29. Santos JN, Sousa SOM, Nunes FD, Sotto, MN. Araújo, VC. Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 2003;30(4):237-41.
30. Soussi T, Legros Y, Lubin R. Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer. 1994;57(1):1-9.
31. Tron VA, Trotter MJ. Tang L, et al. p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am J Pathol 1998;153:579-85.
32. Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A. p53, mdm2, and p21 expression in oral squamous cell carcinomas: Relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94(5):593-600.